Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
18/05/2026 08:07
May 18 (Reuters) - Piramal Pharma Ltd PIRM.NS: PIRAMAL PHARMA LTD - ANNOUNCES SUCCESSFUL CLOSURE OF US FDA INSPECTION AT DIGWAL FACILITY PIRAMAL PHARMA LTD - US FDA ISSUES ESTABLISHMENT INSPECTION REPORT Source text: ID:nBSEnYRM5 Further company coverage: PIRM.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio